abstract |
As described in the claims, the present invention relates to an anti-HSV antibody according to the claims, a pharmaceutical composition comprising an effective amount of the antibody, an expression vector comprising a nucleotide sequence encoding the antibody, the nucleotide Host cells comprising the sequence, hybridoma cells capable of producing the antibody, and use of the antibody as a drug, particularly for the manufacture of a drug for prophylactic or therapeutic treatment of HSV-related diseases in a subject About. |